Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 12 (December)

1. CYR61: a new measure of lung cancer outcome.
   Cancer Invest, 25(8): 738-41. [Abstract] [Full-text]
2. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
   J Natl Cancer Inst, 99(23): 1753-67. [Abstract] [Full-text]
3. Primary Ewing's sarcoma family tumors of the lung a case report and review of the literature.
   Jpn J Clin Oncol, 37(11): 874-7. [Abstract] [Full-text]
4. Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung.
   Cancer Imaging, 7: 195-201. [Abstract] [Full-text]
5. E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.
   Int J Cancer, 122(3): 664-71. [Abstract] [Full-text]
6. Passive smoking and lung cancer in Japanese non-smoking women: a prospective study.
   Int J Cancer, 122(3): 653-7. [Abstract] [Full-text]
7. Panel of serum biomarkers for the diagnosis of lung cancer.
   J Clin Oncol, 25(35): 5578-83. [Abstract] [Full-text]
8. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.
   J Clin Oncol, 25(35): 5570-7. [Abstract] [Full-text]
9. Three-gene prognostic classifier for early-stage non small-cell lung cancer.
   J Clin Oncol, 25(35): 5562-9. [Abstract] [Full-text]
10. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    J Clin Oncol, 25(35): 5557-61. [Abstract] [Full-text]
11. Tumor imaging using technetium-99m bound to pH-sensitive peptides.
    Nanomedicine, 3(4): 297-305. [Abstract] [Full-text]
12. Resection of pulmonary metastases from colorectal carcinoma.
    Eur J Surg Oncol, 33: S59-63. [Abstract] [Full-text]
13. Respiratory symptoms in a boy revealing Carney triad.
    Pediatr Blood Cancer, 50(2): 399-401. [Abstract] [Full-text]
14. Sister Mary Joseph's nodule as presenting sign of a desmoplastic small round cell tumor.
    Pediatr Blood Cancer, 50(2): 388-90. [Abstract] [Full-text]
15. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome.
    Oncogene, 26(57): 7825-32. [Abstract] [Full-text]
16. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.
    Am J Respir Cell Mol Biol, 38(1): 95-104. [Abstract] [Full-text]
17. Pulmonary metastatic microangiopathy of colon cancer presenting as a "tree in bud" pattern.
    Br J Radiol, 81(961): e11-2. [Abstract] [Full-text]
18. A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells.
    Biochem Biophys Res Commun, 365(4): 875-81. [Abstract] [Full-text]
19. Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1.
    Biochem Biophys Res Commun, 365(4): 691-7. [Abstract] [Full-text]
20. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
    Int J Radiat Oncol Biol Phys, 70(1): 175-80. [Abstract] [Full-text]
21. Quantitative assessment of range fluctuations in charged particle lung irradiation.
    Int J Radiat Oncol Biol Phys, 70(1): 253-61. [Abstract] [Full-text]
22. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    J Clin Oncol, 25(36): 5785-92. [Abstract] [Full-text]
23. Randomized phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
    J Clin Oncol, 25(36): 5777-84. [Abstract] [Full-text]
24. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
    Cancer Res, 67(24): 12000-6. [Abstract] [Full-text]
25. Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma.
    Cancer Res, 67(24): 11811-20. [Abstract] [Full-text]
26. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Cancer Res, 67(24): 11630-9. [Abstract] [Full-text]
27. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Cancer Res, 67(24): 11601-11. [Abstract] [Full-text]
28. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Cancer Lett, 259(2): 177-85. [Abstract] [Full-text]
29. Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
    AJR Am J Roentgenol, 190(1): 246-52. [Abstract] [Full-text]
30. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions.
    AJR Am J Roentgenol, 190(1): 234-9. [Abstract] [Full-text]
31. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
    Mol Pharmacol, 73(1): 119-27. [Abstract] [Full-text]
32. Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies.
    J Pharmacol Exp Ther, 324(1): 15-22. [Abstract] [Full-text]
33. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.
    J Gen Intern Med, 23: 78-84. [Abstract] [Full-text]
34. Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase.
    Int J Cancer, 122(4): 791-5. [Abstract] [Full-text]
35. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
    Int J Cancer, 122(4): 915-8. [Abstract] [Full-text]
36. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
    Expert Rev Anticancer Ther, 8(1): 87-98. [Abstract] [Full-text]
37. Lung cancers missed on chest radiographs: results obtained with a commercial computer-aided detection program.
    Radiology, 246(1): 273-80. [Abstract] [Full-text]
38. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening.
    Radiology, 246(1): 265-72. [Abstract] [Full-text]
39. The characteristics and failure pattern of gefitinib responders with postoperative recurrence of pulmonary adenocarcinoma.
    Eur J Surg Oncol, 34(1): 89-93. [Abstract] [Full-text]
40. Pulmonary lymphangioma.
    Ann Thorac Surg, 85(1): 336-9. [Abstract] [Full-text]
41. Treatment of chylothorax by robotic thoracic duct ligation.
    Ann Thorac Surg, 85(1): 334-6. [Abstract] [Full-text]
42. Squamous cell carcinoma in a postpneumonectomy cavity.
    Ann Thorac Surg, 85(1): 333-4. [Abstract] [Full-text]
43. Extrapulmonary ventilation for unresponsive severe acute respiratory distress syndrome after pulmonary resection.
    Ann Thorac Surg, 85(1): 237-44; discussion 244. [Abstract] [Full-text]
44. Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications.
    Ann Thorac Surg, 85(1): 231-5; discussion 235-6. [Abstract] [Full-text]
45. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.
    Ann Thorac Surg, 85(1): 224-30. [Abstract] [Full-text]
46. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Ann Thorac Surg, 85(1): 216-23. [Abstract] [Full-text]
47. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Ann Thorac Surg, 85(1): 211-5. [Abstract] [Full-text]
48. Resected synchronous primary malignant lung tumors: a population-based study.
    Ann Thorac Surg, 85(1): 204-9. [Abstract] [Full-text]
49. A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.
    Hum Mutat, 29(1): 113-22. [Abstract] [Full-text]
50. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.
    Proc Natl Acad Sci U S A, 104(52): 20932-7. [Abstract] [Full-text]
51. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
    J Clin Oncol, 26(1): 60-5. [Abstract] [Full-text]
52. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    J Clin Oncol, 26(1): 54-9. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.